- Established
as an industry leader in psychedelics, chosen as headline partner for
PSYCH
- Importance
of mental health has been brought to the forefront during COVID-19
pandemic
- Changing
public opinion of psychedelics for medicinal purposes with help of
psychedelic events such as PSYCH
Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496),
a research-driven company specializing in the formulation and distribution of a
suite of artisanal mushroom health supplements, will be the headline partner
for Prohibition Partners LIVE’s PSYCH: The Psychedelics Symposium (PSYCH) (http://ibn.fm/YBNMG). Slated for
June 22-23, 2020, this Prohibition Partners LIVE event brings together health
care, science and business leaders from around the world to discuss new
findings in the cannabis and psychedelic space.
Recent legal changes in the cannabis space have opened space
for changing public perception of psychedelics as well as the legal research
for medicinal use. As a headline partner for this premier gathering, Champignon
will be actively involved in the two-day symposium, which features five virtual
stages and will include topics such as:
- Psychedelics
101
- Psychedelics
as medicine
- Psychedelics
for substance-use disorders
- Psychedelics:
the cure for treatment-resistant depression
- Psychedelic
for well-being
- Next
steps for investors
“The impact of COVID-19 has put greater emphasis on the
importance of mental health,” Prohibition Partners’ managing director Stephen
Murphy stated in a news release. “Consumers are looking for options to improve
their mental health and, as the body of evidence mounts for psychedelics, the
healthcare industry is responding with solutions. We’re delighted to partner
with Champignon Brands on PSYCH and support their vision of improving mental
health via psychedelics.”
As an industry leader in innovative treatments using
psychedelics for mental-health conditions, SHRM currently has three trials in
phase 1, three trials in the preclinical stage and seven IP patents for
ketamine/psilocybin delivery platforms and formulations. The company is quickly
establishing a clinical pipeline and drug-development platform in medicinal
psychedelics as well as promoting the health and wellness benefits of
functional mushrooms. SHRM believes that through sustainable organic, non-GMO
and vegan-growing practices combined with commercial cultivation, R&D and
the distribution of its products, the company can enhance the health and
wellness of millions.
According to an article in Forbes (http://ibn.fm/9f5JL), psychedelic
events are becoming mainstream when the focus is on mental health. These
substances have been misunderstood, much as cannabis was, but that is changing
with the help of virtual platforms such as Prohibition Partners LIVE and
opportunities to join leaders on a global stage to discuss the research-backed
breakthroughs in the industry.
SHRM specializes in the formulation and distribution of a
suite of medicinal mushroom health products as well as novel ketamine,
anaesthetics and adaptogenic delivery platforms that promote holistic health
and wellness. The company’s portfolio is focused on the health-conscious
consumer and offers organic teas, coffees and other consumables. Mushroom
infused teas and accessories are available to the consumer on the flagship
e-commerce store, VitalitySuperTeas.com
For more information, visit the company’s website at www.ChampignonBrands.com
NOTE TO INVESTORS: The latest news and updates
relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment